127.
Allison A Brown. Dietary modulation of endothelial function: implica
tions for cardiovascular disease / A Brown Allison and В Hu Frank // Ameri
can Journal of Clinical Nutrition, 2001. - №4. - V.673-686.
128.
American Association for Respiratory Care (AARC) Clinical practice-
guideline: spirometry, 1996 update // Respir. Care. - 1996. - Vol. 41. -P. 629-
636.
129
American Association for Respiratory Care (AARC) Clinical practice-
guideline: Body plethysmography: 2001 Revision and Update Respir.Care. -
2001. - Vol. 45. - P. 506-523.
130.
American Thoracic Society. Standards for the diagnosis and care with
chronic obstructive pulmonary disease / Am Rev Respir Dis. - 1995. - P. I 52
131.
Antezana A.M. Pulmonary hypertension inhigh-altitude chronic hypox
ia: response to nifedipine / A.M. Antezana, G. Antezana, O. Aparicio // Lur.
Respir. J. - 1998. - Vol. 12. - P. 1181-5312.
132.
Appleton S. Longacting beta2agonists for chronic obstructive pulmo
nary disease. (Cochran Review) / S. Appleton, B. Smith, A. Veale
/7
In: The
Cochran Library. Issue 4. - 2001. Oxford Update Software.
133.
Barnes P. J Mechanisms in COPD. Differences From Asthma /' P.J.
Barnes. - Chest 2000. - P. 117.
134.
Barnes P. J Muscarinic receptor subtypes in airways / P.J Barnes. - Life
Sci, 1993. - P. 52.
135.
Barnes P.J. The pharmacological properties of tiotropium / P.J. Barnes
J. Chest 2000; - P. I 17
136.
Brutsaert D. Cardiac endothelium and myocardial function / D Brut-
saert, P. Fransen, L. Andries // Cardiovasc. Res. - 1998. - Vol. 38. - P. 281-
290.
137.
Casaburi R. The spirometric efficacy of once daily dosing with tiotro
pium in stable COPD / R.Casaburi, D.D. Briggs, J.F. Donohue. - Chest, 2000.
- 1
18
p .
132
